5AM Ventures β 2015 Investments
7 investments dated 2015 Β· listed companies and verified rows first Β· show all
Pulmatrix develops inhaled dry-powder therapies using its proprietary iSPERSE technology, which uses small, dense, dispersible particles to deliver respiratory and non-respiratory drugs via the respiratory system.
BiotechDeep TechHealthtechMedical DevicesFramingham, US
Anand Varadan(Director)Richard Batycky(Director)Peter Ludlum(Interim CEO; Interim CFO)Hojabr Alimi(Executive Officer)Sameer Harish(Executive Officer)
BoardRichard Conley(Director)
Board seatScott RocklageΒ· per SEC Form D
Co-investorsARCH Venture PartnersPolaris Partners
Pharmaceutical company developing medicines and vaccines for patient health and treatment.
BiotechHealthtechSan Diego, US
Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)inKevin Forrest(Executive Officer)Dirk Thye(Executive Officer)Ken Bartizal(Executive Officer)Paul Daruwala(Executive Officer)
Board seatScott RocklageΒ· per SEC Form D
Co-investorsAisling CapitalBain Capital Life SciencesFrazier Life SciencesRA CapitalVivo CapitalCanaan Partners+1 more
BiotechBurlingame, US
John Celebi(Executive Officer)Mary Haak-Frendscho(Executive Officer, Director)
BoardCarl Gordon(Director)inDavid Goeddel(Director)Robert Schreiber(Director)
Board seatJohn DiekmanΒ· per SEC Form D Β· $6.3M raise Β· filed Jan 2015
Co-investorsOrbiMedThe Column Group
South San Francisco, US
Geoffrey Richardson(Executive Officer)Howard Turner(Executive Officer, Director)
BoardDipender Saluja(Director)Sam Bergh(Director)Suk-Bae Cha(Director)
Board seatScott RocklageΒ· per SEC Form D Β· $54.6M raise Β· filed Jun 2018
Co-investorsTechnology Impact
BiotechVancouver
Andrew Booth(Director)Andrew J. Schwab(Director)inR. James Taylor(Executive Officer, Director)Joe Victor(Executive Officer, Director)Euan Ramsay(Executive Officer)Daniel Nixon(Director)
Board seatAndrew J. SchwabΒ· per SEC Form D Β· $13.4M raise Β· filed Nov 2016
Co-investorsRising TideTelegraph Hill Partners
BiotechLexington, US
Robert Clarke(Chief Executive Officer and Member of the Board of Directors)David Hava(Chief Scientific Officer)David Edwards(Director)
BoardSteven Gillis(Director)Terrance McGuire(Director)David Maki(Director)
Board seatScott RocklageΒ· per SEC Form D Β· $34.1M raise Β· filed Jun 2015
Co-investorsPolaris Partners
VBI Vaccines is a biopharmaceutical company developing vaccine candidates using virus-like particle (VLP) platforms, including proprietary enveloped VLP and mRNA-launched eVLP technologies.
BiotechHealthtechCambridge, US
Marc Kirchmeier(Vice President, Formulation Development)Egidio Nascimento(Chief Financial Officer)David Anderson(Senior Vice President, Research)Jeff Baxter(President and Chief Executive Officer)Adam T. Buckley(Vice President, Business Development)Murray G. Smith(Executive Officer)
Co-investorsARCH Venture PartnersClarus VenturesK2 HealthVentures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.